CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,298,517 | -19.6% | 28,608 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $1,614,979 | -37.5% | 28,767 | -49.6% | 0.00% | -50.0% |
| Q1 2023 | $2,584,080 | +46.5% | 57,132 | +31.6% | 0.00% | 0.0% |
| Q4 2022 | $1,764,332 | -27.5% | 43,403 | +16.6% | 0.00% | 0.0% |
| Q3 2022 | $2,433,000 | +20.4% | 37,227 | +11.9% | 0.00% | 0.0% |
| Q2 2022 | $2,021,000 | -37.6% | 33,255 | -35.5% | 0.00% | -33.3% |
| Q1 2022 | $3,238,000 | -28.9% | 51,590 | -14.1% | 0.00% | -25.0% |
| Q4 2021 | $4,551,000 | -53.7% | 60,057 | -31.6% | 0.00% | -55.6% |
| Q3 2021 | $9,826,000 | -23.5% | 87,786 | +10.7% | 0.01% | -25.0% |
| Q2 2021 | $12,839,000 | +68.7% | 79,307 | +27.0% | 0.01% | +50.0% |
| Q1 2021 | $7,609,000 | -19.3% | 62,448 | +1.4% | 0.01% | -20.0% |
| Q4 2020 | $9,429,000 | +90.8% | 61,586 | +4.2% | 0.01% | +66.7% |
| Q3 2020 | $4,943,000 | +21.7% | 59,094 | +6.9% | 0.01% | +20.0% |
| Q2 2020 | $4,061,000 | +71.1% | 55,266 | -1.2% | 0.01% | +25.0% |
| Q1 2020 | $2,373,000 | -23.0% | 55,950 | +10.5% | 0.00% | 0.0% |
| Q4 2019 | $3,083,000 | +36.1% | 50,628 | -8.4% | 0.00% | +33.3% |
| Q3 2019 | $2,266,000 | -9.3% | 55,274 | +4.2% | 0.00% | -25.0% |
| Q2 2019 | $2,498,000 | +35.5% | 53,030 | +2.8% | 0.00% | +33.3% |
| Q1 2019 | $1,843,000 | +32.9% | 51,597 | +6.3% | 0.00% | +50.0% |
| Q4 2018 | $1,387,000 | -27.8% | 48,557 | +12.1% | 0.00% | -33.3% |
| Q3 2018 | $1,922,000 | -60.0% | 43,330 | -47.0% | 0.00% | -62.5% |
| Q2 2018 | $4,807,000 | +27.7% | 81,806 | -0.6% | 0.01% | +14.3% |
| Q1 2018 | $3,763,000 | +93.5% | 82,331 | -0.6% | 0.01% | +75.0% |
| Q4 2017 | $1,945,000 | +123.6% | 82,838 | +70.2% | 0.00% | +100.0% |
| Q3 2017 | $870,000 | +171.0% | 48,660 | +143.2% | 0.00% | +100.0% |
| Q2 2017 | $321,000 | – | 20,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |